355829-23-1 Usage
Uses
Used in Pharmaceutical Industry:
2-Chloro-4-(dimethylamino)-5-fluoropyrimidine serves as an intermediate in the synthesis of pharmaceuticals. Its specific functional groups and structural features make it a valuable component in the development of new drugs, potentially contributing to the creation of medications with novel therapeutic effects and mechanisms of action.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Chloro-4-(dimethylamino)-5-fluoropyrimidine is utilized as an intermediate in the production of agrochemicals. Its chemical properties allow it to be incorporated into compounds that can be used for pest control, crop protection, and other agricultural applications, thereby enhancing crop yields and quality.
Used in Fine Chemicals Industry:
2-Chloro-4-(dimethylamino)-5-fluoropyrimidine also finds application as an intermediate in the synthesis of other fine chemicals. Its versatility in organic chemistry facilitates the production of specialty chemicals used in various industries, such as dyes, fragrances, and advanced materials, where its unique attributes can be leveraged to achieve specific functional requirements.
Check Digit Verification of cas no
The CAS Registry Mumber 355829-23-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,5,8,2 and 9 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 355829-23:
(8*3)+(7*5)+(6*5)+(5*8)+(4*2)+(3*9)+(2*2)+(1*3)=171
171 % 10 = 1
So 355829-23-1 is a valid CAS Registry Number.
InChI:InChI=1/C6H7ClFN3/c1-11(2)5-4(8)3-9-6(7)10-5/h3H,1-2H3
355829-23-1Relevant articles and documents
2-PHENYLAMINOPYRIMIDINE DERIVATIVES AS KINASE LRRK2 MODULATORS FOR THE TREATMENT OF PARKINSON'S DISEASE
-
Page/Page column 55, (2013/06/27)
Specific Compounds of formula (I): or pharmaceutically acceptable salts thereof, wherein m, X, R, R2, R3, R, R6 and R7 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
AMINOPYRIMIDINE DERIVATIVES AS LRRK2 INHIBITORS
-
Page/Page column 20, (2011/12/14)
Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n. X, R1, R2, R3, R5, R6 and R7 are as defined herein. Also disclosed are methods of making the compound